Study of MT-5111 in HER2-positive Solid Tumors

Macquarie University Hospital (Clinical Trials Unit), Macquarie

Southern Highlands Cancer Centre, Bowral

Sunshine Hospital - Western Health, Saint Albans

St. Vincent's Hospital Melbourne, Fitzroy

Goulburn Valley Health, Shepparton

Cancer Research South Australia, Adelaide

New Zealand Clinical Research (Christchurch), Christchurch

Novant Health Forsyth Medical Center, Winston-Salem

Novant Health Cancer Institute, Charlotte

Prisma Health, Greenville

Mayo Clinic (Florida), Jacksonville

Orlando Health, Orlando

South Broward Hospital District d/b/a Memorial Healthcare System, Hollywood

South Broward Hospital District d/b/a Memorial Healthcare System, Pembroke Pines

Sylvester Comprehensive Cancer Center (University of Miami), Coral Gables

BRCR Medical Center, Plantation

Sarah Cannon Research Institute, Nashville

University of Michigan, Ann Arbor

Mayo Clinic (Minnesota), Rochester

Northwestern University, Chicago

University of Chicago Medical Center, Chicago

Washington University, St Louis

Mary Crowley Cancer Research, Dallas

The University of Texas Health Science Center, San Antonio

Sarah Cannon Research Institute, Denver

Mayo Clinic (Arizona), Phoenix

Cedars-Sinai Medical Center, Santa Monica

UCLA Hematology & Oncology, Santa Monica

Cancer and Blood Specialty Clinic, Los Alamitos

St. Joseph Heritage Healthcare, Fullerton